IANNONE, ROSA FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 869
EU - Europa 454
AS - Asia 425
SA - Sud America 78
AF - Africa 17
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.846
Nazione #
US - Stati Uniti d'America 852
SG - Singapore 179
RU - Federazione Russa 120
IE - Irlanda 89
CN - Cina 85
HK - Hong Kong 60
BR - Brasile 57
DE - Germania 55
SE - Svezia 55
VN - Vietnam 47
FR - Francia 31
UA - Ucraina 26
FI - Finlandia 17
IT - Italia 14
GB - Regno Unito 12
CZ - Repubblica Ceca 10
IN - India 10
CA - Canada 9
EC - Ecuador 8
AT - Austria 7
BD - Bangladesh 6
MX - Messico 6
DZ - Algeria 5
IQ - Iraq 5
NL - Olanda 5
PK - Pakistan 5
UZ - Uzbekistan 5
PL - Polonia 4
VE - Venezuela 4
AR - Argentina 3
IR - Iran 3
LT - Lituania 3
TR - Turchia 3
ZA - Sudafrica 3
AZ - Azerbaigian 2
CO - Colombia 2
EG - Egitto 2
JP - Giappone 2
KG - Kirghizistan 2
MA - Marocco 2
NP - Nepal 2
SA - Arabia Saudita 2
SN - Senegal 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
ES - Italia 1
GY - Guiana 1
HN - Honduras 1
ID - Indonesia 1
JO - Giordania 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
PW - Palau 1
RO - Romania 1
SC - Seychelles 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 1.846
Città #
Dallas 418
San Jose 142
Dublin 88
Singapore 83
Hong Kong 60
Ashburn 53
Chandler 34
Nyköping 34
Beijing 32
Munich 32
Lauterbourg 20
Santa Clara 20
Ho Chi Minh City 18
Los Angeles 18
The Dalles 14
Hanoi 13
Helsinki 13
Jacksonville 13
Columbus 12
Moscow 12
Brno 10
Nuremberg 10
Princeton 7
Wilmington 7
Chicago 6
London 6
Amsterdam 5
Brooklyn 5
Falkenstein 5
Frankfurt am Main 4
Guangzhou 4
Loja 4
New York 4
Shanghai 4
Tashkent 4
Toronto 4
Turku 4
Xi'an 4
Algiers 3
Boston 3
Chennai 3
Guayaquil 3
Hải Dương 3
Mexico City 3
Paris 3
Rio de Janeiro 3
São Paulo 3
Vienna 3
Warsaw 3
Baghdad 2
Baku 2
Caracas 2
Dakar 2
Dhaka 2
Foggia 2
Guiyang 2
Haiphong 2
Hillsboro 2
Islamabad 2
Lahore 2
Milan 2
Montevideo 2
New Delhi 2
Phoenix 2
Rome 2
Seattle 2
Tokyo 2
Washington 2
Welland 2
Abuja 1
Aci Catena 1
Ahmedabad 1
Amman 1
Amparo 1
Andradina 1
Ankara 1
Antalya 1
Araçatuba 1
Arraial do Cabo 1
Aryanah 1
Ash Shuhada' 1
Astrakhan 1
Atlanta 1
Azcapotzalco 1
Baguio City 1
Balsas 1
Bari 1
Batam 1
Belo Horizonte 1
Benoni 1
Bethany 1
Bishkek 1
Blumenau 1
Boardman 1
Bom Jesus 1
Brasília 1
Bucaramanga 1
Buon Ma Thuot 1
Bắc Giang 1
Bến Lức 1
Totale 1.330
Nome #
Transthoracic Lung Ultrasound in Systemic Sclerosis-Associated Interstitial Lung Disease: Capacity to Differentiate Chest Computed-Tomographic Characteristic Patterns 182
Nintedanib in Rheumatoid Arthritis–Related Interstitial Lung Disease: Real-World Safety Profile and Risk of Side Effects and Discontinuation 139
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry 122
Italian Multicenter Real-World Study on the Twelve-Month Effectiveness, Safety, and Retention Rate of Guselkumab in Psoriatic Arthritis Patients 120
ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis - A EUSTAR analysis 112
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis 109
Preliminary data on post market safety profiles of covid 19 vaccines in rheumatic diseases: Assessments on various vaccines in use, different rheumatic disease subtypes, and immunosuppressive therapies: A two-centers study 107
What have multicentre registries across the world taught us about the disease features of systemic sclerosis? 96
Golimumab effectiveness in biologic inadequate responding patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis in real-life from the Italian registry GISEA 88
Factors predicting early discontinuation of methotrexate as a first-line treatment for rheumatoid arthritis in Italy: Results from the GISEA registry 84
Thoracic lymphadenopathy as possible predictor of the onset of interstitial lung disease in systemic sclerosis patients without lung involvement at baseline visit: A retrospective analysis 79
Racial differences in systemic sclerosis disease presentation: A European Scleroderma Trials and Research group study 78
Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium 71
Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients 65
Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab: results from the Italian GISEA registry 59
Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: A EUSTAR database analysis 59
Comorbidities in the Spondyloarthritis GISEA Cohort: an average treatment effect analysis on patients treated with bDMARDs 55
Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research 54
Expert consensus on the treatment of patients with adult-onset still's disease with the goal of achieving an early and long-term remission 52
Effectiveness of ixekizumab over 24 months in different clinical scenarios in psoriatic arthritis: results from the Gruppo Italiano Studio Early Arthritis multicentric prospective registry 50
Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database 50
Real-world effectiveness and persistence of golimumab as second-line anti-TNFα drug in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis patients in Italy: GO-BEYOND, a 12-month prospective observational study 47
Does regression of skin thickening predict improvement of internal organ involvement and survival in patients with diffuse cutaneous systemic sclerosis? A EUSTAR analysis 46
Corrigendum to ‘Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: data from the EuroSpA collaboration’ [Seminars in Arthritis and Rheumatism 56 (2022) 1-13/152081] (Seminars in Arthritis and Rheumatism (2022) 56, (S0049017222001329), (10.1016/j.semarthrit.2022.152081)) 21
Totale 1.945
Categoria #
all - tutte 9.467
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.467


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 0 0 0 7 1 0
2021/202260 0 1 0 0 7 1 0 6 11 24 0 10
2022/2023205 14 11 12 5 9 20 0 22 92 5 13 2
2023/202479 4 3 6 6 8 12 0 1 0 6 7 26
2024/2025352 15 5 4 13 7 53 42 28 78 31 38 38
2025/20261.187 69 147 436 71 37 44 171 104 51 57 0 0
Totale 1.945